Aleddra Launches Award-Winning LumiBé™ Table Lamp on Indiegogo
Combining 40Hz invisible gamma rhythm and Near-Infrared (NIR) lighting to preserve brain vitality and illuminate memory.
As we age, our brain's core focus rhythm—the Gamma Frequency—will naturally decline, silently impacting our focus, memory, and logic. Traditional cognitive solutions often come with heavy financial burdens or uncomfortable side effects. But what if the solution was as simple as turning on a light?
Unlike traditional light therapy that uses a harsh, unbearable strobing, LumiBé™ delivers an invisible Gamma Rhythm therapy that is completely comfortable for the eyes. This light triggers a natural process called neural entrainment, encouraging your brain's natural rhythms to sync to their ideal frequency to support a healthy cognitive environment.
The results are clinically validated. In a double-blind study, users experiencing this non-invasive Gamma Rhythm stimulation showed a 95% improvement in visual memory and a 158% improvement in verbal memory as compared to the control group. Additionally, LumiBé™ integrates Near-Infrared (NIR) lighting technology, providing multimodal wellness benefits, including mood stabilization, blood pressure regulation, and heart rate reduction.
"LumiBé™ is more than just a lamp—it represents a new approach to daily cognitive wellness,"
Early backers can secure exclusive campaign pricing and limited Super Early Bird discounts on Indiegogo at https://www.indiegogo.com/en/projects/aleddra/lumibe-table-lamp.
To learn more about 40Hz Gamma Stimulation and Cognitive Wellness, join Aleddra's 30-minute live webinar, open to everyone. Register at https://www.aleddra.com/webinar-registration-form/.
Media Contact:
425.430.4555
View original content to download multimedia:https://www.prnewswire.com/news-releases/aleddra-launches-award-winning-lumibe-table-lamp-on-indiegogo-302880232.html
SOURCE Aleddra LED Lighting
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Patterson & O'Neill Partner Chris Manasserian Named a Southern California Commercial Real Estate Visionary by LA Times Studios
- /C O R R E C T I O N -- International Paper/
- Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share